Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1989 1
1990 1
1995 2
1996 2
1997 1
1998 4
1999 3
2000 1
2001 2
2002 4
2004 1
2005 3
2006 1
2008 5
2009 2
2010 2
2012 2
2016 1
2017 3
2018 2
2019 1
2020 1
2021 2
2022 1
2023 2
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.
de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, Ottevanger PB, Ledermann JA, Khaw P, Colombo A, Fyles A, Baron MH, Jürgenliemk-Schulz IM, Kitchener HC, Nijman HW, Wilson G, Brooks S, Carinelli S, Provencher D, Hanzen C, Lutgens LCHW, Smit VTHBM, Singh N, Do V, D'Amico R, Nout RA, Feeney A, Verhoeven-Adema KW, Putter H, Creutzberg CL; PORTEC study group. de Boer SM, et al. Lancet Oncol. 2018 Mar;19(3):295-309. doi: 10.1016/S1470-2045(18)30079-2. Epub 2018 Feb 12. Lancet Oncol. 2018. PMID: 29449189 Free PMC article. Clinical Trial.
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial.
de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, Ottevanger PB, Ledermann JA, Khaw P, D'Amico R, Fyles A, Baron MH, Jürgenliemk-Schulz IM, Kitchener HC, Nijman HW, Wilson G, Brooks S, Gribaudo S, Provencher D, Hanzen C, Kruitwagen RF, Smit VTHBM, Singh N, Do V, Lissoni A, Nout RA, Feeney A, Verhoeven-Adema KW, Putter H, Creutzberg CL; PORTEC Study Group. de Boer SM, et al. Lancet Oncol. 2019 Sep;20(9):1273-1285. doi: 10.1016/S1470-2045(19)30395-X. Epub 2019 Jul 22. Lancet Oncol. 2019. PMID: 31345626 Free PMC article. Clinical Trial.
Diagnostics in athletes with long-standing groin pain.
Jansen JA, Mens JM, Backx FJ, Stam HJ. Jansen JA, et al. Among authors: mens jm. Scand J Med Sci Sports. 2008 Dec;18(6):679-90. doi: 10.1111/j.1600-0838.2008.00848.x. Epub 2008 Oct 13. Scand J Med Sci Sports. 2008. PMID: 18980608 Review.
The use of medication in low back pain.
Mens JM. Mens JM. Best Pract Res Clin Rheumatol. 2005 Aug;19(4):609-21. doi: 10.1016/j.berh.2005.03.011. Best Pract Res Clin Rheumatol. 2005. PMID: 15949779 Review.
An anthropomorphic deformable phantom of the vaginal wall and cavity.
Somerwil PC, Nout RA, Mens JM, Kolkman-Deurloo IK, van Beekhuizen HJ, Dankelman J, van de Berg NJ. Somerwil PC, et al. Among authors: mens jm. Biomed Phys Eng Express. 2021 Aug 16;7(5). doi: 10.1088/2057-1976/ac1780. Biomed Phys Eng Express. 2021. PMID: 34298530
Treatment of longstanding groin pain in athletes: a systematic review.
Jansen JA, Mens JM, Backx FJ, Kolfschoten N, Stam HJ. Jansen JA, et al. Among authors: mens jm. Scand J Med Sci Sports. 2008 Jun;18(3):263-74. doi: 10.1111/j.1600-0838.2008.00790.x. Epub 2008 Apr 6. Scand J Med Sci Sports. 2008. PMID: 18397195 Review.
52 results